Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (342)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
31
2026
191
13.090
 Why?
Anticonvulsants
20
2025
136
8.750
 Why?
Seizures
24
2025
201
6.150
 Why?
Tuberous Sclerosis
8
2025
37
4.230
 Why?
Spasms, Infantile
11
2025
31
4.110
 Why?
Cannabidiol
8
2025
44
3.910
 Why?
Status Epilepticus
6
2021
34
3.250
 Why?
Epilepsies, Myoclonic
5
2024
15
3.010
 Why?
Mutation
16
2023
1331
2.980
 Why?
Deep Brain Stimulation
4
2025
42
2.760
 Why?
Humans
120
2026
52441
2.680
 Why?
Electroencephalography
18
2024
301
2.440
 Why?
Child
45
2026
7194
2.290
 Why?
Intellectual Disability
5
2023
127
2.140
 Why?
Brain
10
2024
1337
2.060
 Why?
Hemiplegia
3
2021
12
1.950
 Why?
Developmental Disabilities
5
2019
125
1.630
 Why?
Epilepsy, Absence
3
2019
11
1.590
 Why?
Magnetic Resonance Imaging
16
2025
1507
1.570
 Why?
Infant
24
2025
3709
1.530
 Why?
Genetic Therapy
2
2025
127
1.450
 Why?
Algorithms
2
2025
673
1.360
 Why?
Tumor Suppressor Proteins
3
2023
127
1.360
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.350
 Why?
Nervous System Malformations
3
2020
16
1.350
 Why?
Folate Receptor 1
2
2022
27
1.320
 Why?
Child, Preschool
23
2026
4046
1.310
 Why?
Infant, Newborn, Diseases
2
2020
56
1.240
 Why?
Epilepsies, Partial
2
2022
15
1.240
 Why?
Ketamine
2
2020
61
1.230
 Why?
Vagus Nerve Stimulation
2
2025
14
1.130
 Why?
Neurocutaneous Syndromes
2
2019
6
1.110
 Why?
Cadherins
2
2019
61
1.100
 Why?
Cerebral Arteries
2
2019
30
1.020
 Why?
Male
40
2026
26874
1.020
 Why?
Epilepsy, Generalized
2
2023
9
1.000
 Why?
Female
36
2026
28277
1.000
 Why?
Vigabatrin
3
2024
3
1.000
 Why?
Sirolimus
2
2017
72
0.980
 Why?
Tic Disorders
1
2026
4
0.970
 Why?
Neurosurgical Procedures
3
2026
134
0.970
 Why?
Angiofibroma
2
2015
5
0.960
 Why?
Facial Neoplasms
2
2015
22
0.940
 Why?
Treatment Outcome
13
2025
5508
0.930
 Why?
Nerve Tissue Proteins
2
2018
201
0.930
 Why?
Valproic Acid
2
2022
35
0.920
 Why?
Stroke
3
2019
527
0.880
 Why?
Fenfluramine
2
2024
7
0.880
 Why?
Dioxolanes
2
2024
16
0.860
 Why?
Randomized Controlled Trials as Topic
2
2024
625
0.860
 Why?
Thalamus
1
2024
35
0.860
 Why?
Pregnanolone
2
2023
6
0.840
 Why?
Adolescent
18
2026
6713
0.810
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.790
 Why?
Quality Improvement
2
2022
226
0.760
 Why?
Aphasia
1
2022
36
0.740
 Why?
Nervous System Diseases
2
2021
96
0.730
 Why?
Chromosome Deletion
3
2019
138
0.720
 Why?
Abnormalities, Multiple
3
2023
164
0.720
 Why?
Emergencies
1
2021
78
0.690
 Why?
Pharmaceutical Preparations
1
2021
73
0.690
 Why?
Angelman Syndrome
1
2020
1
0.680
 Why?
Transition to Adult Care
1
2020
23
0.660
 Why?
Bone Diseases, Developmental
2
2023
17
0.660
 Why?
Tooth Abnormalities
2
2023
13
0.650
 Why?
Immunoglobulins, Intravenous
1
2021
63
0.650
 Why?
Oligonucleotides, Antisense
1
2020
29
0.640
 Why?
Phenobarbital
1
2020
17
0.640
 Why?
Flunarizine
1
2019
1
0.640
 Why?
Immunologic Factors
1
2021
114
0.640
 Why?
Behavioral Symptoms
1
2019
4
0.640
 Why?
Excitatory Amino Acid Antagonists
1
2020
49
0.630
 Why?
Ocular Physiological Phenomena
1
2019
3
0.620
 Why?
Tetrasomy
1
2019
2
0.620
 Why?
Agenesis of Corpus Callosum
2
2018
9
0.620
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.620
 Why?
Sneddon Syndrome
1
2019
3
0.620
 Why?
Livedo Reticularis
1
2019
5
0.620
 Why?
Calcium Channel Blockers
1
2019
60
0.610
 Why?
Oral Ulcer
1
2019
3
0.610
 Why?
Behcet Syndrome
1
2019
7
0.610
 Why?
Transposases
1
2019
11
0.610
 Why?
Andersen Syndrome
1
2019
1
0.600
 Why?
Hydrocephalus
1
2019
41
0.600
 Why?
Spinal Cord Diseases
1
2019
38
0.600
 Why?
Receptors, GABA-B
1
2019
11
0.600
 Why?
Vitiligo
1
2019
8
0.600
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.600
 Why?
Leukoencephalopathies
1
2019
15
0.590
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.590
 Why?
Edema
1
2019
63
0.590
 Why?
Migraine Disorders
2
2020
45
0.590
 Why?
Physicians
1
2022
237
0.590
 Why?
Cerebral Infarction
1
2018
35
0.590
 Why?
Electron Transport Complex IV
1
2018
24
0.590
 Why?
Cannabinoid Receptor Agonists
1
2019
49
0.580
 Why?
Muscle Weakness
1
2019
45
0.580
 Why?
Optic Atrophy
1
2018
13
0.580
 Why?
Nephrotic Syndrome
2
2017
34
0.580
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.580
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.580
 Why?
Photic Stimulation
1
2018
55
0.580
 Why?
Alopecia
1
2019
38
0.580
 Why?
Shab Potassium Channels
1
2018
2
0.580
 Why?
Brain Edema
1
2018
37
0.570
 Why?
Parents
1
2021
339
0.560
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
30
0.560
 Why?
Artifacts
1
2018
53
0.560
 Why?
Thrombocytopenia
1
2019
93
0.560
 Why?
Myoclonus
1
2018
10
0.560
 Why?
Autoimmune Diseases
1
2019
87
0.560
 Why?
Biomedical Research
1
2021
260
0.550
 Why?
Mitochondrial Diseases
1
2018
44
0.550
 Why?
Neurodegenerative Diseases
1
2018
83
0.540
 Why?
Practice Guidelines as Topic
1
2020
498
0.540
 Why?
Health Knowledge, Attitudes, Practice
1
2021
504
0.530
 Why?
Models, Biological
1
2020
735
0.520
 Why?
Osteochondrodysplasias
1
2017
14
0.520
 Why?
Immunologic Deficiency Syndromes
1
2017
18
0.520
 Why?
Hearing Loss, Sensorineural
1
2018
80
0.520
 Why?
Arteriosclerosis
1
2017
49
0.520
 Why?
Carotid Artery Diseases
1
2017
32
0.520
 Why?
Infant, Newborn
6
2024
2871
0.520
 Why?
Phenotype
2
2021
792
0.520
 Why?
Drug Discovery
1
2017
94
0.510
 Why?
Prenatal Exposure Delayed Effects
1
2018
196
0.500
 Why?
Cafe-au-Lait Spots
1
2016
2
0.500
 Why?
Child Development
1
2018
208
0.500
 Why?
Skin
1
2019
416
0.490
 Why?
Williams Syndrome
1
2016
24
0.490
 Why?
Migraine with Aura
1
2015
4
0.490
 Why?
Erythema Infectiosum
1
2015
3
0.490
 Why?
Corpus Callosum
2
2023
26
0.490
 Why?
Pulmonary Embolism
1
2017
81
0.490
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.490
 Why?
Syndrome
6
2024
247
0.480
 Why?
Sinus Pericranii
1
2015
1
0.480
 Why?
Parvovirus B19, Human
1
2015
16
0.480
 Why?
Toes
1
2015
15
0.480
 Why?
Electrodiagnosis
1
2015
12
0.480
 Why?
SOS1 Protein
1
2015
2
0.480
 Why?
Crying
1
2015
4
0.480
 Why?
Moyamoya Disease
1
2015
7
0.480
 Why?
Hyperventilation
1
2015
8
0.470
 Why?
Iatrogenic Disease
1
2015
25
0.470
 Why?
Tuberculoma
1
2015
1
0.470
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.470
 Why?
Noonan Syndrome
1
2015
12
0.470
 Why?
Neurologic Examination
1
2015
73
0.470
 Why?
Encephalitis
1
2016
39
0.470
 Why?
Communication
3
2022
255
0.470
 Why?
Ocular Motility Disorders
1
2015
16
0.460
 Why?
Mutism
1
2015
3
0.460
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.460
 Why?
Repressor Proteins
2
2023
150
0.460
 Why?
TOR Serine-Threonine Kinases
1
2015
83
0.460
 Why?
Retrospective Studies
9
2026
6694
0.460
 Why?
Diagnosis, Differential
7
2020
1028
0.460
 Why?
Trisomy
1
2014
35
0.450
 Why?
KCNQ2 Potassium Channel
1
2014
8
0.440
 Why?
Energy Drinks
1
2014
6
0.440
 Why?
Influenza, Human
1
2015
90
0.440
 Why?
Neurology
1
2015
39
0.440
 Why?
Vasoconstriction
1
2014
56
0.430
 Why?
Benzodiazepines
1
2014
71
0.430
 Why?
Osteomyelitis
1
2015
125
0.420
 Why?
Membrane Proteins
1
2016
344
0.420
 Why?
Enzyme Inhibitors
1
2015
378
0.400
 Why?
Sleep
1
2014
191
0.400
 Why?
Palliative Care
2
2026
194
0.390
 Why?
Quality of Life
4
2025
893
0.380
 Why?
Magnetic Resonance Angiography
3
2019
67
0.380
 Why?
Immunosuppressive Agents
3
2019
248
0.370
 Why?
Consensus
2
2025
195
0.370
 Why?
Pediatrics
1
2015
302
0.360
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
126
0.330
 Why?
Clinical Trials as Topic
2
2024
461
0.330
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
131
0.330
 Why?
Caregivers
2
2021
239
0.300
 Why?
Recurrence
3
2019
680
0.300
 Why?
Echinocandins
1
2008
64
0.290
 Why?
Mycoses
1
2008
152
0.270
 Why?
Gastroesophageal Reflux
2
2019
50
0.260
 Why?
Antifungal Agents
1
2008
347
0.240
 Why?
Administration, Topical
2
2015
62
0.240
 Why?
Adult
6
2025
14205
0.230
 Why?
Seizures, Febrile
1
2024
3
0.230
 Why?
Meta-Analysis as Topic
1
2024
39
0.220
 Why?
Magnetoencephalography
1
2025
90
0.220
 Why?
Memory, Short-Term
1
2025
77
0.220
 Why?
Neuropsychological Tests
1
2026
346
0.220
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.210
 Why?
Psychosurgery
1
2023
5
0.210
 Why?
Databases, Factual
2
2024
721
0.210
 Why?
Comorbidity
1
2026
637
0.210
 Why?
Laser Therapy
1
2023
74
0.200
 Why?
Speech Disorders
1
2022
17
0.200
 Why?
Ethosuximide
1
2022
5
0.190
 Why?
Clonazepam
1
2022
6
0.190
 Why?
Cluster Analysis
1
2023
236
0.190
 Why?
Electrodes, Implanted
1
2022
37
0.190
 Why?
Stereotaxic Techniques
1
2022
41
0.190
 Why?
Death, Sudden
1
2022
9
0.190
 Why?
GTPase-Activating Proteins
1
2022
24
0.190
 Why?
Concept Formation
1
2021
13
0.180
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.180
 Why?
Freedom
1
2021
3
0.180
 Why?
Folic Acid
1
2022
137
0.180
 Why?
Diazepam
1
2021
18
0.180
 Why?
Drug Interactions
1
2022
198
0.180
 Why?
Fibroma
1
2021
40
0.180
 Why?
Adrenocorticotropic Hormone
2
2022
32
0.170
 Why?
Personal Satisfaction
1
2021
74
0.170
 Why?
Soft Tissue Neoplasms
1
2021
56
0.170
 Why?
Risk Factors
2
2020
3971
0.170
 Why?
Brain Diseases
1
2021
80
0.170
 Why?
Dihydroergotamine
1
2020
4
0.170
 Why?
Perception
1
2021
121
0.170
 Why?
Transcription Factors
2
2023
570
0.170
 Why?
Mental Disorders
1
2025
427
0.170
 Why?
Facies
2
2023
36
0.160
 Why?
Diet Therapy
1
2020
8
0.160
 Why?
Genetic Diseases, Inborn
1
2020
25
0.160
 Why?
Clinical Protocols
1
2020
106
0.160
 Why?
Treatment Failure
1
2020
117
0.160
 Why?
Anesthetics
1
2020
37
0.160
 Why?
Learning
1
2021
158
0.160
 Why?
Leukomalacia, Periventricular
1
2019
12
0.160
 Why?
Muscle Hypotonia
1
2019
23
0.160
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.150
 Why?
Matrix Attachment Region Binding Proteins
1
2020
38
0.150
 Why?
HLA-B51 Antigen
1
2019
2
0.150
 Why?
Ubiquitin-Protein Ligases
1
2020
132
0.150
 Why?
Analgesics, Non-Narcotic
1
2020
118
0.150
 Why?
Ventriculoperitoneal Shunt
1
2019
28
0.150
 Why?
Qualitative Research
1
2021
365
0.150
 Why?
Craniofacial Abnormalities
1
2019
27
0.150
 Why?
Patient-Centered Care
1
2021
141
0.150
 Why?
Heart Septal Defects, Atrial
1
2019
45
0.150
 Why?
Disease Management
1
2020
185
0.150
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.150
 Why?
Ventricular Premature Complexes
1
2019
7
0.150
 Why?
Microcephaly
1
2019
40
0.150
 Why?
Referral and Consultation
1
2021
288
0.150
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
 Why?
Facial Nerve Diseases
1
2018
6
0.150
 Why?
Syncope
1
2019
31
0.150
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
 Why?
Cerebral Veins
1
2018
17
0.140
 Why?
Facial Paralysis
1
2018
25
0.140
 Why?
Health Personnel
1
2021
255
0.140
 Why?
Anti-Arrhythmia Agents
1
2019
79
0.140
 Why?
Deglutition Disorders
1
2019
76
0.140
 Why?
Fatal Outcome
1
2019
193
0.140
 Why?
Acute Disease
1
2019
384
0.140
 Why?
Fibrinolytic Agents
1
2019
131
0.140
 Why?
Frameshift Mutation
1
2018
18
0.140
 Why?
Video Recording
1
2018
79
0.140
 Why?
Combined Modality Therapy
1
2020
641
0.140
 Why?
Anti-Inflammatory Agents
1
2019
166
0.140
 Why?
Fear
1
2018
84
0.140
 Why?
India
1
2017
60
0.140
 Why?
Cerebellum
1
2018
129
0.140
 Why?
History, 21st Century
1
2017
60
0.130
 Why?
Platelet Aggregation Inhibitors
1
2019
211
0.130
 Why?
History, 20th Century
1
2017
100
0.130
 Why?
Neurotoxicity Syndromes
1
2017
46
0.130
 Why?
Methotrexate
1
2017
76
0.130
 Why?
Pandemics
1
2021
580
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
90
0.130
 Why?
Animals
3
2022
13485
0.130
 Why?
Anti-Infective Agents
1
2017
106
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
24
0.120
 Why?
Influenza B virus
1
2015
6
0.120
 Why?
Hormones
1
2016
57
0.120
 Why?
Delayed Diagnosis
1
2016
29
0.120
 Why?
Arkansas
1
2021
2013
0.120
 Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
 Why?
North America
1
2015
75
0.120
 Why?
Cerebral Angiography
1
2015
90
0.110
 Why?
Complementary Therapies
1
2015
23
0.110
 Why?
Antibiotics, Antineoplastic
1
2015
83
0.110
 Why?
Chromosomes, Human, Pair 9
1
2014
20
0.110
 Why?
Brain Waves
1
2014
19
0.110
 Why?
Drug Resistance
1
2015
69
0.110
 Why?
Antiemetics
1
2014
32
0.110
 Why?
Polymerase Chain Reaction
1
2015
458
0.110
 Why?
Headache
1
2014
74
0.110
 Why?
Vomiting
1
2014
71
0.110
 Why?
Glutamine
1
2015
177
0.100
 Why?
Mutation, Missense
1
2014
108
0.100
 Why?
Arginine
1
2015
183
0.100
 Why?
Decision Making, Computer-Assisted
1
2013
3
0.100
 Why?
Analgesics
1
2014
106
0.100
 Why?
Diagnostic Errors
1
2013
69
0.100
 Why?
Evidence-Based Medicine
1
2013
271
0.090
 Why?
Inflammation
1
2016
649
0.090
 Why?
Pregnancy
1
2018
2642
0.090
 Why?
Signal Transduction
1
2017
1724
0.080
 Why?
Antineoplastic Agents
1
2017
1216
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.070
 Why?
Eosinophils
1
2009
39
0.070
 Why?
Lipopeptides
1
2008
61
0.070
 Why?
Amyloidosis
1
2009
85
0.070
 Why?
Tuberculosis
1
2009
127
0.070
 Why?
Candidiasis
1
2008
112
0.070
 Why?
Aspergillosis
1
2008
122
0.070
 Why?
Inflammatory Bowel Diseases
1
2009
87
0.070
 Why?
Kidney Diseases
1
2009
230
0.060
 Why?
Prospective Studies
2
2023
2433
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2025
49
0.060
 Why?
Observer Variation
1
2024
134
0.050
 Why?
Spasm
1
2024
9
0.050
 Why?
Feedback
1
2024
52
0.050
 Why?
Kaplan-Meier Estimate
1
2025
485
0.050
 Why?
Probability
1
2023
171
0.050
 Why?
Young Adult
2
2025
4346
0.050
 Why?
Neuroimaging
1
2023
91
0.050
 Why?
Pilot Projects
1
2025
725
0.050
 Why?
Potassium Channels
1
2021
31
0.040
 Why?
Cohort Studies
1
2026
1576
0.040
 Why?
Reproducibility of Results
1
2024
1223
0.040
 Why?
Registries
1
2024
638
0.040
 Why?
Administration, Intravenous
1
2020
73
0.040
 Why?
Sleep Stages
1
2020
41
0.040
 Why?
Age of Onset
1
2020
109
0.040
 Why?
Follow-Up Studies
1
2025
2294
0.040
 Why?
Cognition
1
2022
363
0.040
 Why?
Immunohistochemistry
1
2021
977
0.040
 Why?
Aged
1
2025
10242
0.020
 Why?
Internet
1
2013
262
0.020
 Why?
Software
1
2013
281
0.020
 Why?
Middle Aged
1
2025
13133
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
84
0.020
 Why?
Colonoscopy
1
2009
105
0.020
 Why?
Prognosis
1
2009
2100
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (342) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department